We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+4.99%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$110B
AUM Growth
+$11.3B
(+11%)
Cap. Flow
+$8.89B
Cap. Flow
% of AUM
8.09%
Top 10 Holdings %
Top 10 Hldgs %
35.27%
Holding
3,643
New
809
Increased
972
Reduced
1,047
Closed
744
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$3.35B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$2.85B |
| 3 |
Eli Lilly
LLY
|
+$999M |
| 4 |
Coca-Cola
KO
|
+$685M |
| 5 |
Broadcom
AVGO
|
+$616M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.38B |
| 2 |
Apple
AAPL
|
+$1.12B |
| 3 |
Netflix
NFLX
|
+$678M |
| 4 |
Boston Scientific
BSX
|
+$671M |
| 5 |
Cencora
COR
|
+$627M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.19% |
| 2 | Consumer Discretionary | 12.77% |
| 3 | Healthcare | 10.45% |
| 4 | Financials | 7.74% |
| 5 | Communication Services | 5.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1176
Crown Castle
CCI
$32.7B
| $4.54M | ﹤0.01% |
51,085
-400,660
| -89% | -$36.8M |
|
1177
Sylvamo
SLVM
$1.52B
| $4.52M | ﹤0.01% |
93,950
+45,250
| +93% | +$2.06M |
|
1178
GSI Technology
GSIT
$216M
| $4.52M | ﹤0.01% |
727,077
+385,185
| +113% | +$2.75M |
|
|
EHAB
1179
DELISTED
Enhabit
EHAB
| $4.49M | ﹤0.01% |
487,408
-305,573
| -39% | -$2.65M |
|
1180
Automatic Data Processing
ADP
$100B
| $4.46M | ﹤0.01% |
+17,355
| New | +$4.62M |
|
1181
Clearfield
CLFD
$421M
| $4.45M | ﹤0.01% |
152,684
-10,103
| -6% | -$325K |
|
1182
Amtech Systems
ASYS
$278M
| $4.43M | ﹤0.01% |
352,624
+247,352
| +235% | +$2.23M |
|
1183
Knowles
KN
$3.22B
| $4.42M | ﹤0.01% |
206,023
-52,064
| -20% | -$1.19M |
|
1184
Enova International
ENVA
$5.91B
| $4.41M | ﹤0.01% |
+28,067
| New | +$3.65M |
|
1185
Olin
OLN
$2.64B
| $4.4M | ﹤0.01% |
211,078
+185,400
| +722% | +$4M |
|
1186
Assembly Biosciences
ASMB
$506M
| $4.39M | ﹤0.01% |
129,075
+43,860
| +51% | +$1.41M |
|
|
SARO
1187
StandardAero Inc
SARO
$9.54B
| $4.39M | ﹤0.01% |
153,052
+27,801
| +22% | +$757K |
|
|
MRX
1188
Marex Group Limited Ordinary Shares
MRX
$4.72B
| $4.39M | ﹤0.01% |
114,417
-542,163
| -83% | -$18.4M |
|
1189
ASP Isotopes
ASPI
$487M
| $4.38M | ﹤0.01% |
818,129
-460,992
| -36% | -$3.67M |
|
1190
Ormat Technologies
ORA
$6.11B
| $4.37M | ﹤0.01% |
39,600
+700
| +2% | +$76.6K |
|
1191
Phillips Edison & Co
PECO
$5.48B
| $4.37M | ﹤0.01% |
+122,966
| New | +$4.27M |
|
1192
BJ's Restaurants
BJRI
$1.41B
| $4.37M | ﹤0.01% |
+111,001
| New | +$3.94M |
|
1193
PUT
Palantir
PLTR
$295B
| $4.37M | ﹤0.01% |
24,600
-163,600
| -87% | -$29.6M |
|
1194
Amplify Energy
AMPY
$163M
| $4.36M | ﹤0.01% |
954,725
+413,512
| +76% | +$2.06M |
|
1195
Nicolet Bankshares
NIC
$3.57B
| $4.33M | ﹤0.01% |
+35,668
| New | +$4.51M |
|
1196
Genesco
GCO
$396M
| $4.32M | ﹤0.01% |
174,218
+121,814
| +232% | +$3.49M |
|
|
FPI
1197
Farmland Partners
FPI
$419M
| $4.29M | ﹤0.01% |
443,151
+285,440
| +181% | +$2.86M |
|
1198
Phillips 66
PSX
$82.9B
| $4.29M | ﹤0.01% |
33,268
-341,316
| -91% | -$45.9M |
|
1199
Cullinan Oncology
CGEM
$1.05B
| $4.29M | ﹤0.01% |
414,359
+118,917
| +40% | +$1.07M |
|
1200
Ezcorp Inc
EZPW
$1.82B
| $4.28M | ﹤0.01% |
220,485
-389,167
| -64% | -$7.34M |
|
Similar funds
Marshall Wace's Q4 2025 Portfolio in Review
As of Q4 2025, Marshall Wace held 3,643 positions worth $110B, up 11% from $98.6B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Marshall Wace deployed $8.89B of net new capital in Q4 2025, opening 809 new positions and adding to 972 existing holdings. Its largest new stake was Vanguard S&P 500 ETF: 4,580,704 shares worth $2.87B.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 20% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Microsoft, an estimated $1.38B trimmed.
- Marshall Wace's largest Q4 2025 buy was Vanguard S&P 500 ETF: 4,580,704 shares worth $2.87B.
- Marshall Wace added most to iShares Core S&P 500 ETF in Q4 2025, an estimated $3.35B increase.
- Marshall Wace's biggest Q4 2025 reduction was Microsoft, cutting an estimated $1.38B.
- Marshall Wace fully exited Ares Management in Q4 2025, selling an estimated $146M.
- Marshall Wace's ten largest holdings make up 35% of its $110B portfolio in Q4 2025.
- Marshall Wace opened 809 new positions and closed 744 in Q4 2025.
- Marshall Wace's portfolio value rose 11% quarter-over-quarter to $110B.
Based on Marshall Wace's 13F filing for Q4 2025, filed 13 Feb 2026.